Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31824 total
AMGN has lost nearly 5% this week and 8% over the past month, closing at $402.60, and the most interesting tension right now is that short sellers are quietly retreating while the analyst community grows more…
COR is heading into its November 4 earnings date with the stock up 2.9% on the week, analysts lifting targets, and short sellers quietly retreating, a setup that looks more constructive than it has for much of…
AIG heads into the final weeks before its November 3 earnings with a small but accelerating short book and a Street divided between patient bulls and cautious neutrals. The most interesting tension this week is the…
American Express heads into its October 23 earnings report with the Street's price targets falling faster than the stock itself, a gap that frames everything worth watching on this name right now. The analyst pressure…
AMZN added 3.9% on the week to close at $256.29, putting the October 29 Q3 report just 22 days away and prompting a fresh round of analyst target upgrades that collectively widen the gap between where the stock trades…
ALL enters its October 28 earnings date with the Street uniformly trimming price targets and the stock down 14% over the past month, creating a clear tension between a still-positive consensus and a rapidly narrowing…
ALB heads into November earnings with short interest running near its highest level in months, options traders cautiously defensive, and a Street that keeps lowering the bar even as it mostly holds its buy…
Alaska Air Group arrives at its October 20 earnings date with a familiar story: short interest near 10% of float, a wave of analyst target cuts, and a stock that has barely moved in a week while the rest of the airline…
Akamai Technologies heads into its November 3 earnings with a notable tension at its core: short sellers hold a large position but are quietly trimming, while analysts cluster around hold ratings well below the current…
Agilent Technologies pulled back 3.3% on the week to close at $169.33, a modest retreat after a 12.2% gain over the prior month, and the most interesting tension right now is whether that pullback invites re-entry or…
AMD closed Tuesday at $649.42, up 7% on the week, and for the first time since its recent rally began, the stock has decisively cleared the consensus analyst mean price target. The catalyst this week was concentrated…
AEHR heads into its October 12 results with the sharpest single-day drop of the year still fresh and short sellers pressing a position that has grown 20% over the past month. Tuesday's 11.7% fall to $92.14 set the tone…
ADBE has steadied after last week's sell-off, but the picture around it has become more uncomfortable: the stock gained 2.1% on the week to $238.12 while closest peers surged past it, and the Street's post-earnings…
Abbott Laboratories arrives at its October 14 Q3 print having shed 9.4% over the past month, with the Street firmly bullish and the market sending more ambiguous signals. Barclays initiated coverage this week with an…
AFL heads into its November 4 earnings date with analyst opinion pulling in opposite directions and its largest institutional shareholder quietly reducing its position through a pre-arranged sale plan. The most…
Nebius Group enters October with its stock up 5.3% on the week to $249.87, yet the short position remains stubbornly large and the analyst community is as divided as it has been all year. Short interest has barely…
FITB closes out the week at $51.00, down 7% on the month but essentially flat over the past five days. That contrast sets the tone: the stock has stabilised near-term, yet the bigger picture has deteriorated heading…
Karman Holdings enters October with a split story: insiders buying at open-market prices while short sellers hold their ground at one of the highest levels in the aerospace and defense sector. The insider angle is the…
Iovance Biotherapeutics is unwinding some of last week's squeeze gains, with the stock down 10% on the week to $12.96, and short sellers who survived the guidance-driven surge now seeing the first meaningful relief in…
GRPN heads into November earnings with short interest near historic highs, an activist on the register, and options traders more bullish than they have been all year. Short sellers remain deeply committed to the…
